Skip to content

Medical Thoracoscopy in the treatment of recurrent primary spontaneous pneumothorax-a single-center, prospective, single-arm study

Medical Thoracoscopy in the treatment of recurrent primary spontaneous pneumothorax-a single-center, prospective, single-arm study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125015
Enrollment
Unknown
Registered
2026-05-20
Start date
2026-05-20
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent primary spontaneous pneumothorax

Interventions

Intervention Group:Treatment with APC Combined with Human Albumin Medical Adhesive via Medical Thoracoscopy

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 14 and 50 years; 2. A chest X-ray or CT scan from the current visit shows unilateral pneumothorax; 3. A chest CT scan shows pulmonary bullae on the affected side; 4. The air leak has persisted for more than 3 days; 5. History of pneumothorax on the same or opposite side.

Exclusion criteria

Exclusion criteria: 1. Imaging findings indicating a pulmonary bulla with a diameter =5 cm; 2. History of prior surgery on the same side of the chest or pleural fixation; 3. Tension pneumothorax; 4. Secondary spontaneous pneumothorax (i.e., iatrogenic, traumatic, or caused by underlying pulmonary disease); 5. Bilateral pneumothorax; 6. Hemothorax; 7. Pregnancy or lactation; 8. Active pulmonary infection; 9. Inability to tolerate medical thoracoscopy due to hemodynamic instability (blood pressure =90/60 mmHg) or severe hypoxemia (PaO2/FiO2 < 250); 10. Coagulation disorders.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of pneumothorax 12 months postoperatively;

Secondary

MeasureTime frame
Resorption of pneumothorax 8 weeks postoperatively;Time to air leak cessation;Time to chest tube removal;Recurrence rate of pneumothorax 2 years postoperatively;Recurrence rate of pneumothorax 5 years postoperatively;Patient satisfaction score;VAS scores within one week postoperatively;Complications associated with treatment regimens;

Countries

China

Contacts

Public ContactKaige Wang

West China Hospital, Sichuan University,

youjiangbuyi@163.com+86 28 8542 3331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026